Literature DB >> 21653672

Influenza A virus N5 neuraminidase has an extended 150-cavity.

Mingyang Wang1, Jianxun Qi, Yue Liu, Christopher J Vavricka, Yan Wu, Qing Li, George F Gao.   

Abstract

There are 9 serotypes of neuraminidase (NA) from influenza A virus (N1 to N9), which are classified into two groups based on primary sequences (groups 1 and 2). The structural hallmark of the two groups is the presence or absence of an extra 150-cavity (formed by the 150-loop) in the active site. Thus far, structures of NAs from 6 out of the 9 serotypes have been solved. Here, we solved the N5 structure, the last unknown structure group 1 serotype with a unique Asn147 residue in its 150-loop, demonstrating that it has an extended 150-cavity that closes upon inhibitor binding.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21653672      PMCID: PMC3147963          DOI: 10.1128/JVI.00638-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.

Authors:  Y S Babu; P Chand; S Bantia; P Kotian; A Dehghani; Y El-Kattan; T H Lin; T L Hutchison; A J Elliott; C D Parker; S L Ananth; L L Horn; G W Laver; J A Montgomery
Journal:  J Med Chem       Date:  2000-09-21       Impact factor: 7.446

2.  Structure of a calcium-deficient form of influenza virus neuraminidase: implications for substrate binding.

Authors:  Brian J Smith; Trevor Huyton; Robbie P Joosten; Jennifer L McKimm-Breschkin; Jian Guo Zhang; Cindy S Luo; Mei Zhen Lou; Nikolaos E Labrou; Thomas P J Garrett
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2006-08-19

Review 3.  The neuraminidase of influenza virus.

Authors:  G M Air; W G Laver
Journal:  Proteins       Date:  1989

Review 4.  Structures of influenza A proteins and insights into antiviral drug targets.

Authors:  Kalyan Das; James M Aramini; Li-Chung Ma; Robert M Krug; Eddy Arnold
Journal:  Nat Struct Mol Biol       Date:  2010-04-11       Impact factor: 15.369

5.  Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus.

Authors:  Wei Zhang; Jianxun Qi; Yi Shi; Qing Li; Feng Gao; Yeping Sun; Xishan Lu; Qiong Lu; Christopher J Vavricka; Di Liu; Jinghua Yan; George F Gao
Journal:  Protein Cell       Date:  2010-06-04       Impact factor: 14.870

6.  Crystallization and preliminary X-ray studies of influenza A virus neuraminidase of subtypes N5, N6, N8 and N9.

Authors:  G Taylor; E Garman; R Webster; T Saito; G Laver
Journal:  J Mol Biol       Date:  1993-03-05       Impact factor: 5.469

7.  Structure of the catalytic and antigenic sites in influenza virus neuraminidase.

Authors:  P M Colman; J N Varghese; W G Laver
Journal:  Nature       Date:  1983 May 5-11       Impact factor: 49.962

8.  Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution.

Authors:  J N Varghese; W G Laver; P M Colman
Journal:  Nature       Date:  1983 May 5-11       Impact factor: 49.962

9.  The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site.

Authors:  Qing Li; Jianxun Qi; Wei Zhang; Christopher J Vavricka; Yi Shi; Jinhua Wei; Enguang Feng; Jingshan Shen; Jilong Chen; Di Liu; Jianhua He; Jinghua Yan; Hong Liu; Hualiang Jiang; Maikun Teng; Xuebing Li; George F Gao
Journal:  Nat Struct Mol Biol       Date:  2010-09-19       Impact factor: 15.369

10.  CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity.

Authors:  Makoto Yamashita; Takanori Tomozawa; Masayo Kakuta; Akane Tokumitsu; Hatsumi Nasu; Shuku Kubo
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

View more
  34 in total

1.  Binding of herpes simplex virus glycoprotein D to nectin-1 exploits host cell adhesion.

Authors:  Na Zhang; Jinghua Yan; Guangwen Lu; Zhengfei Guo; Zheng Fan; Jiawei Wang; Yi Shi; Jianxun Qi; George F Gao
Journal:  Nat Commun       Date:  2011-12-06       Impact factor: 14.919

2.  Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase.

Authors:  Jennifer L McKimm-Breschkin; Janelle Williams; Susan Barrett; Kim Jachno; Mandy McDonald; Peter G Mohr; Takehiko Saito; Masato Tashiro
Journal:  J Antimicrob Chemother       Date:  2013-06-11       Impact factor: 5.790

3.  Implications of protein conformations to modifying novel inhibitor Oseltamivir for 2009 H1N1 influenza A virus by simulation and docking studies.

Authors:  Sudha Singh; Anvita Gupta Malhotra; Mohit Jha; Khushhali Menaria Pandey
Journal:  Virusdisease       Date:  2018-09-01

4.  Molecular Characterizations of Surface Proteins Hemagglutinin and Neuraminidase from Recent H5Nx Avian Influenza Viruses.

Authors:  Hua Yang; Paul J Carney; Vasiliy P Mishin; Zhu Guo; Jessie C Chang; David E Wentworth; Larisa V Gubareva; James Stevens
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

5.  The neuraminidase of bat influenza viruses is not a neuraminidase.

Authors:  Adolfo García-Sastre
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-25       Impact factor: 11.205

6.  The significance of naturally occurring neuraminidase quasispecies of H5N1 avian influenza virus on resistance to oseltamivir: a point of concern.

Authors:  Nalini Schaduangrat; Jiraphorn Phanich; Thanyada Rungrotmongkol; Hatairat Lerdsamran; Pilaipan Puthavathana; Sukathida Ubol
Journal:  J Gen Virol       Date:  2016-03-02       Impact factor: 3.891

7.  Functional and structural analysis of influenza virus neuraminidase N3 offers further insight into the mechanisms of oseltamivir resistance.

Authors:  Qing Li; Jianxun Qi; Yan Wu; Hiromasa Kiyota; Kosuke Tanaka; Yoshitomo Suhara; Hiroshi Ohrui; Yasuo Suzuki; Christopher J Vavricka; George F Gao
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

8.  Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.

Authors:  Won-Suk Choi; Ju Hwan Jeong; Jin Jung Kwon; Su Jeong Ahn; Khristine Kaith S Lloren; Hyeok-Il Kwon; Hee Bok Chae; Jungwon Hwang; Myung Hee Kim; Chul-Joong Kim; Richard J Webby; Elena A Govorkova; Young Ki Choi; Yun Hee Baek; Min-Suk Song
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

9.  Crystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site.

Authors:  Xueyong Zhu; Hua Yang; Zhu Guo; Wenli Yu; Paul J Carney; Yan Li; Li-Mei Chen; James C Paulson; Ruben O Donis; Suxiang Tong; James Stevens; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

10.  Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.

Authors:  Yan Wu; Feng Gao; Jianxun Qi; Yuhai Bi; Lifeng Fu; Sankar Mohan; Yuhang Chen; Xuebing Li; B Mario Pinto; Christopher J Vavricka; Po Tien; George F Gao
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.